Patent Number: 7,611,845

Title: Serum levels of HER2/neu as an indicator of clinical state and prognosis of prostate cancer

Abstract: The present invention relates to methods of diagnosing prostate cancer, predicting disease progression of prostate cancer, prognosing the stage and state of prostate cancer, and identifying appropriate treatment indication for prostate cancer patients. Methods encompass determining the levels of HER-2/neu in fluid biological samples (e.g., blood and serum) from patients.

Inventors: Taneja; Samir (Wyckoff, NJ), Cheli; Carol D. (Mahopac, NY)

Assignee: Siemens Healthcare Diagnostics Inc.

International Classification: G01N 33/53 (20060101); G01N 33/574 (20060101)

Expiration Date: 1/03/02017